T21-01-2015 17-52-00he team at the Imperial College Memory Research Unit, led by Dr Paul Edison, is researching Alzheimer’s disease and mild cognitive impairment (a midway stage between normal age-related memory loss and the more serious decline of dementia).

The team use PET and MRI scans to explore the mechanisms that lead to dementia, with the ultimate goal of finding better ways to diagnose and treat the condition. They were one of the first groups to develop imaging technology to detect amyloid in the brain.

Currently, the team is conducting several studies. One is called the ELAD study, and is assessing whether a drug used to treat diabetes could also be effective for Alzheimer’s.

Another study, looking at neuroinflammation, is exploring the underlying disease processes.

Both of these studies are currently recruiting volunteers.

‘Join dementia research’ (JDR) has made an enormous difference. Recruitment has been faster and easier than ever before.

“JDR is an excellent way of recruiting patients, as it matches the study with appropriate patients. It’s an excellent source for finding participants,” Paul reported.

“Because patients have already been on the  website, we have their details. They also know about our studies, and have expressed an interest in taking part. So it brings the ideal patients closer to the researchers”.

In the past, patients have been recruited via memory clinics, or by placing adverts in GP surgeries and the local press. Finding the right people has often been a lengthy and time-consuming process.

“We first had to find people who matched our inclusion and exclusion criteria. Then we had to find out if those people were willing to take part and then check that they weren’t too advanced in their disease to be able to give consent”, explained Paul.

“JDR has been very helpful because people are effectively pre-screened. Patients go on and register their details to see if they match any study’s requirements – so you already know if they might be a good fit. It also provides us with  people who are interested in research, so half the battle is over”.

Dr Melanie Dani, a clinical research fellow for the study at Imperial College London, has been using ‘Join dementia research’ for three months.Melanie

“It’s been great! I’ve enrolled five people. Five more are booked to be enrolled and I’m in contact with dozens more. I get two or three new names every day”.

Melanie leads on recruitment to the neuroinflammation study. She explained the steps involved;

“We put our criteria into the JDR website and that finds people who match our study information only. We can access their contact details and also know how they’d prefer to be contacted. Usually we send them an email first. We then screen them on the phone and send them further information if they are interested.

Then we follow-up and if they agree to take part, bring them into our system. It’s a more direct route to patients, so a much faster process”.

The team had some concerns about whether they would be able to recruit to the neuroinflammation study.

“It’s an observational study. There’s no treatment being tested, so there are no direct benefits to the patients taking part. We’re also recruiting people with only mild cognitive impairment. These are the people who are a bit worried about their memory but otherwise are functioning very well. It’s a tiny window. Not everyone seeks medical advice at that point, so it’s not often officially diagnosed”, explained Melanie.

However, JDR has helped overcome these difficulties. It has proved to be a valuable source of willing, enthusiastic volunteers.

“The people who have already signed-up are so well-informed and interested in our research. They know our studies are extremely important to help us understand the disease”, Melanie said.

JDR_cmyk“I think it’s great that a lot of patients are told about JDR at the memory clinics and through the charities. It means everyone has access wherever they are, and can easily find the studies suitable for them”.